ArticleDiscover oncology2025
New therapeutic targets and mechanisms of papillary thyroid carcinoma identified by multi-omics analysis.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Myeloid landscape of BRAF-mutant papillary thyroid cancer and thyroiditis.Endocrine-related cancer · 2026Article
- The relationship between the extent of extrathyroidal extension and lymph node metastasis based on propensity score matching analysis.Gland surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionThe treatment of papillary thyroid carcinoma (PTC) presents ongoing challenges, underscoring the need for novel therapeutic targets.
methodsThis study employed proteomic MR analysis, utilizing publicly available data from genome-wide association studies (GWAS) and protein quantitative trait loci (pQTL) studies. We analyzed proteomic data from deCODE and the UK Biobank Protein Project (UKB-PP), along with GWAS data on papillary thyroid carcinoma (PTC) from the Finnish Consortium. This analysis was further supported by eQTL validation and bioinformatics differential analysis to identify potential therapeutic targets for PTC. Additionally, we explored possible downstream mechanisms of the target proteins through mediation analysis.
resultsOur analysis identified two potential therapeutic targets associated with PTC, specifically, LY75 and S100A12. Mediation analysis further investigated their potential mechanistic role in the pathogenesis of PTC.
conclusionThrough multi-omics analysis, we identified new potential therapeutic targets for papillary thyroid carcinoma and investigated their possible underlying mechanisms affecting PTC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.